Territory Account Manager - Middletown, NJ at HeartFlow

Middletown, New Jersey, United States

Apply Now

$125,000 – $140,000Compensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Technology, CardiovascularIndustries

Requirements

Proven sales skills and track-record of sales achievement
Account development - Experience building and supporting strong clinical programs is preferred
Clinical / technical proficiency - Quick learner able to grasp new clinical/technical information and then disseminate to customers
Ability to develop relationships with key stakeholders (e.g., referring physicians, clinical stakeholders)

Responsibilities

Work with key strategic Heartflow accounts to drive growth and adoption of a cCTA and FFRct clinical pathway, developing and executing business development plans with key stakeholders
Facilitate cross-functional collaboration throughout the organization, using tools such as deployment of Heartflow internal leadership and physician mentors, organizing dinner programs, VIP Visits, CT Pathway road-shows, and referring physician office meetings; work closely with Territory Sales Manager, Marketing, Market Access, CT Apps, Product Development, and Clinical teams
Increase Heartflow usage within designated key strategic accounts by maintaining and building relationships with referring physicians and other key clinical stakeholders
Educate customers on Heartflow’s value proposition through presentations and discussions with referring MDs
Promote / champion Heartflow and build advocacy
Meet / exceed quota for strategic Heartflow accounts (within existing customer locations)
Drive cCTA growth (conversion of non-invasive tests) and FFRct penetration / case growth over baseline (% and $) in assigned accounts

Skills

Account Management

Territory Management

Sales

Customer Success

Physician Relations

Medical Device Sales

Healthcare Sales

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free